NDC 60432-837
Bromfed DM
Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide
Bromfed DM is a Oral Syrup in the Human Prescription Drug category. It is labeled and distributed by Morton Grove Pharmaceuticals, Inc.. The primary component is Brompheniramine Maleate; Pseudoephedrine Hydrochloride; Dextromethorphan Hydrobromide.
| Product ID | 60432-837_96641a48-5450-44bb-a1ab-25d0cf05f2a6 |
| NDC | 60432-837 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Bromfed DM |
| Generic Name | Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide |
| Dosage Form | Syrup |
| Route of Administration | ORAL |
| Marketing Start Date | 2010-06-15 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA088811 |
| Labeler Name | Morton Grove Pharmaceuticals, Inc. |
| Substance Name | BROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE |
| Active Ingredient Strength | 2 mg/5mL; mg/5mL; mg/5mL |
| Pharm Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC],Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],Sigma-1 Agonist [EPC],Uncompetitive NMDA Receptor Antagonists [MoA],Sigma-1 Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
Packaging
NDC 60432-837-04
118 mL in 1 BOTTLE, PLASTIC (60432-837-04)
| Marketing Start Date | 2010-06-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 60432-837-04 [60432083704]
Bromfed DM SYRUP
| Marketing Category | ANDA |
| Application Number | ANDA088811 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-06-15 |
NDC 60432-837-15 [60432083715]
Bromfed DM SYRUP
| Marketing Category | ANDA |
| Application Number | ANDA088811 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-06-15 |
| Marketing End Date | 2017-07-01 |
NDC 60432-837-16 [60432083716]
Bromfed DM SYRUP
| Marketing Category | ANDA |
| Application Number | ANDA088811 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-06-15 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| BROMPHENIRAMINE MALEATE | 2 mg/5mL |
OpenFDA Data
| SPL SET ID: | e241d83e-996c-494d-b3fe-97f1ef4809ed |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Pharmacological Class
- Adrenergic alpha-Agonists [MoA]
- alpha-Adrenergic Agonist [EPC]
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]
- Sigma-1 Agonist [EPC]
- Uncompetitive NMDA Receptor Antagonists [MoA]
- Sigma-1 Receptor Agonists [MoA]
- Adrenergic alpha-Agonists [MoA]
- alpha-Adrenergic Agonist [EPC]
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]
- Sigma-1 Agonist [EPC]
- Uncompetitive NMDA Receptor Antagonists [MoA]
- Sigma-1 Receptor Agonists [MoA]
Medicade Reported Pricing
60432083716 BROMFED DM COUGH SYRUP
Pricing Unit: ML | Drug Type:
60432083704 BROMFED DM COUGH SYRUP
Pricing Unit: ML | Drug Type:
NDC Crossover Matching brand name "Bromfed DM" or generic name "Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 60432-837 | Bromfed DM | brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide |
| 68025-002 | Bromfed DM | Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide |
| 0574-1104 | Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide | Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide |
| 50090-5625 | Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide | Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide |
| 51862-535 | brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide | brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide |
| 63187-664 | Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide | Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide |
| 63629-8615 | Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide | Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide |
| 63629-8616 | Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide | Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide |
| 68788-6453 | Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide | Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide |
| 68788-7610 | brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide | brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide |
| 71205-346 | brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide | brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide |
| 0527-5302 | Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide | brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide |
| 63629-2085 | Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide | brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide |
| 63629-2086 | Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide | brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide |
Trademark Results [Bromfed DM]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BROMFED DM 74047192 1638857 Live/Registered |
Muro Pharmaceutical, Inc. 1990-04-09 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.